Loading...
Loading...
By MBN Staff - Tue, 10/29/2024 - 16:18
Eli Lilly's Phase 3b ADapt study shows that EBGLYSS improves skin and reduces itch in atopic dermatitis patients not responding to dupilumab.
https://mexicobusiness.news/tag/atopic-dermatitis
More Health
By MBN Staff - Wed, 07/17/2024 - 10:03
Johnson & Johnson acquired Yellow Jersey for US$1.25 billion, securing global rights to a bispecific antibody aimed at treating atopic dermatitis.
By MBN Staff - Mon, 06/10/2024 - 10:16
Study finds higher dietary sodium associated with increased risk of atopic dermatitis (AD) diagnosis, activity, and severity.
By Antonio Gozain - Wed, 06/08/2022 - 11:37
Dupixent, Sanofi’s best-selling drug, received FDA approval to treat atopic dermatitis in children aged six months to five years.
